Anfei Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anfei Li has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Robert N. Weinreb
Hamilton Glaucoma Center, Shiley Eye Institute and Department of Ophthalmology, University of California San Diego, La Jolla, California, USA
2 shared publications - Aakriti Garg Shukla
Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, NY
1 shared publication Amy Hembree
Department of Emergency Medicine, Weill Cornell Medicine, New York City, New York, USA, cornell.edu
1 shared publicationAmylisa Philips
Department of Emergency Medicine, Weill Cornell Medicine, New York City, New York, USA, cornell.edu
1 shared publicationAnika K. Tandon
1 shared publicationCarlos Gustavo De Moraes
Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, NY
1 shared publication
Latest Publications
- 10 July 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 291, 164-173
Differential Impact of Intraocular Pressure Lowering on Glaucoma Progression in African- and European-Descent Individuals
- 10 July 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 291, 164-173
Differential Impact of Intraocular Pressure Lowering on Glaucoma Progression in African- and European-Descent Individuals
- 3 March 2026
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 9 (5) , 543-554
Characterization of Temporal Delay and Modeling of Intraocular Pressure and Visual Field Progression in the African Descent and Glaucoma Evaluation Study
- 3 March 2026
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 9 (5) , 543-554
Characterization of Temporal Delay and Modeling of Intraocular Pressure and Visual Field Progression in the African Descent and Glaucoma Evaluation Study
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1)
The Use of Deep Learning in Distinguishing Chalazion and Eyelid Mass
Purpose: Our study investigated the ability of artificial intelligence to differentiate eyelid lesions to support its potential use as a tool to better inform referrals to oculoplastic surgery specialists by other healthcare providers. Specifically, our study tested artificial intelligence’s ability to distinguish benign chalazia from alternative eyelid masses that may require advanced subspecialized care with oculoplastic specialists. Methods: This retrospective case–control study included 206 photographs of diagnosed chalazia from 183 patients and 517 photographs from 486 patients with non‐chalazia eyelid lesions to train and test a convolutional neural network (CNN). Network architectures including VGG‐16, VGG‐19, ResNet50, Xception, and MobileNetV2 were trained. Their performances were compared using the area under the curve (AUC) as the main outcome metric. Additionally, performances of CNN models were compared to those of frontline physicians. Results: VGG‐16 and VGG‐19 architectures achieved meaningful performance when trained with photographs of chalazion and eyelid mass achieving AUCs of 0.797 and 0.703, respectively. Adjusting detection thresholding allowed the VGG‐16 and VGG‐19 models to achieve sensitivity of 93% and 98% in predicting eyelid mass, respectively. This was an improvement over classification by frontline physicians who achieved an accuracy of 61% and a sensitivity of 65% for mass detection. Conclusions: We showed that using a CNN trained with clinical external photographs could successfully distinguish a chalazion from an alternative eyelid mass, supporting its potential use as a tool for healthcare providers to assist in determining whether a mass requires oculoplastic referral for subspecialty care.
- 1 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1)
Open AccessThe Use of Deep Learning in Distinguishing Chalazion and Eyelid Mass
Purpose: Our study investigated the ability of artificial intelligence to differentiate eyelid lesions to support its potential use as a tool to better inform referrals to oculoplastic surgery specialists by other healthcare providers. Specifically, our study tested artificial intelligence’s ability to distinguish benign chalazia from alternative eyelid masses that may require advanced subspecialized care with oculoplastic specialists. Methods: This retrospective case–control study included 206 photographs of diagnosed chalazia from 183 patients and 517 photographs from 486 patients with non‐chalazia eyelid lesions to train and test a convolutional neural network (CNN). Network architectures including VGG‐16, VGG‐19, ResNet50, Xception, and MobileNetV2 were trained. Their performances were compared using the area under the curve (AUC) as the main outcome metric. Additionally, performances of CNN models were compared to those of frontline physicians. Results: VGG‐16 and VGG‐19 architectures achieved meaningful performance when trained with photographs of chalazion and eyelid mass achieving AUCs of 0.797 and 0.703, respectively. Adjusting detection thresholding allowed the VGG‐16 and VGG‐19 models to achieve sensitivity of 93% and 98% in predicting eyelid mass, respectively. This was an improvement over classification by frontline physicians who achieved an accuracy of 61% and a sensitivity of 65% for mass detection. Conclusions: We showed that using a CNN trained with clinical external photographs could successfully distinguish a chalazion from an alternative eyelid mass, supporting its potential use as a tool for healthcare providers to assist in determining whether a mass requires oculoplastic referral for subspecialty care.
- 26 July 2023
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (1) , 47-52
Early Detection of Optic Nerve Changes on Optical Coherence Tomography Using Deep Learning for Risk-Stratification of Papilledema and Glaucoma
Background: The use of artificial intelligence is becoming more prevalence in medicine with numerous successful examples in ophthalmology. However, much of the work has been focused on replicating the works of ophthalmologists. Given the analytical potentials of artificial intelligence, it is plausible that artificial intelligence can detect microfeatures not readily distinguished by humans. In this study, we tested the potential for artificial intelligence to detect early optic coherence tomography changes to predict progression toward papilledema or glaucoma when no significant changes are detected on optical coherence tomography by clinicians. Methods: Prediagnostic optical coherence tomography of patients who developed papilledema (n = 93, eyes = 166) and glaucoma (n = 187, eyes = 327) were collected. Given discrepancy in average cup-to-disc ratios of the experimental groups, control groups for papilledema (n = 254, eyes = 379) and glaucoma (n = 441, eyes = 739) are matched by cup-to-disc ratio. Publicly available Visual Geometry Group-19 model is retrained using each experimental group and its respective control group to predict progression to papilledema or glaucoma. Images used for training include retinal nerve fiber layer thickness map, extracted vertical tomogram, ganglion cell thickness map, and ILM-RPE thickness map. Results: Trained model was able to predict progression to papilledema with a precision of 0.714 and a recall of 0.769 when trained with retinal nerve fiber layer thickness map, but not other image types. However, trained model was able to predict progression to glaucoma with a precision of 0.682 and recall of 0.857 when trained with extracted vertical tomogram, but not other image types. Area under precision–recall curve of 0.826 and 0.785 were achieved for papilledema and glaucoma models, respectively. Conclusions: Computational and analytical power of computers have become an invaluable part of our lives and research endeavors. Our proof-of-concept study showed that artificial intelligence (AI) algorithms have the potential to detect early changes on optical coherence tomography for prediction of progression that is not readily observed by clinicians. Further research may help establish possible AI models that can assist with early diagnosis or risk stratification in ophthalmology.
- 26 July 2023
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (1) , 47-52
Early Detection of Optic Nerve Changes on Optical Coherence Tomography Using Deep Learning for Risk-Stratification of Papilledema and Glaucoma
Background: The use of artificial intelligence is becoming more prevalence in medicine with numerous successful examples in ophthalmology. However, much of the work has been focused on replicating the works of ophthalmologists. Given the analytical potentials of artificial intelligence, it is plausible that artificial intelligence can detect microfeatures not readily distinguished by humans. In this study, we tested the potential for artificial intelligence to detect early optic coherence tomography changes to predict progression toward papilledema or glaucoma when no significant changes are detected on optical coherence tomography by clinicians. Methods: Prediagnostic optical coherence tomography of patients who developed papilledema (n = 93, eyes = 166) and glaucoma (n = 187, eyes = 327) were collected. Given discrepancy in average cup-to-disc ratios of the experimental groups, control groups for papilledema (n = 254, eyes = 379) and glaucoma (n = 441, eyes = 739) are matched by cup-to-disc ratio. Publicly available Visual Geometry Group-19 model is retrained using each experimental group and its respective control group to predict progression to papilledema or glaucoma. Images used for training include retinal nerve fiber layer thickness map, extracted vertical tomogram, ganglion cell thickness map, and ILM-RPE thickness map. Results: Trained model was able to predict progression to papilledema with a precision of 0.714 and a recall of 0.769 when trained with retinal nerve fiber layer thickness map, but not other image types. However, trained model was able to predict progression to glaucoma with a precision of 0.682 and recall of 0.857 when trained with extracted vertical tomogram, but not other image types. Area under precision–recall curve of 0.826 and 0.785 were achieved for papilledema and glaucoma models, respectively. Conclusions: Computational and analytical power of computers have become an invaluable part of our lives and research endeavors. Our proof-of-concept study showed that artificial intelligence (AI) algorithms have the potential to detect early changes on optical coherence tomography for prediction of progression that is not readily observed by clinicians. Further research may help establish possible AI models that can assist with early diagnosis or risk stratification in ophthalmology.
- Open Access
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S219
311. Role of BDNF and mGluR5 in Modulating Perseverative, Repetitive Behaviors
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S219
Open Access311. Role of BDNF and mGluR5 in Modulating Perseverative, Repetitive Behaviors